These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 34182032)

  • 21. Safety and efficacy of the EPIC™ nitinol vascular stent system for the treatment of lesions located in the superficial femoral artery: prospective and multicentric trial.
    Nasser F; Kambara A; Abath C; Cavalcanti D; Barros I; Pires N; Rivera M; Neser A; Ingrund J; Burihan M; Silveira P; Galego G; Bortoluzzi C; Franklin R; Bosiers M; Deloose K; Razuk A; Caffaro R; Karakhanian WK; Park J; Lopes C; Pinto D; Bez L; Lopes R; Mourão A; Kleinsorge G
    J Cardiovasc Surg (Torino); 2017 Jun; 58(3):409-415. PubMed ID: 25731858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Twelve-Month Outcomes From the Japanese Post-Market Surveillance Study of the Viabahn Endoprosthesis as Treatment for Symptomatic Peripheral Arterial Disease in the Superficial Femoral Arteries.
    Iida O; Ohki T; Soga Y; Suematsu N; Nakama T; Yamaoka T; Tobita K; Ichihashi S
    J Endovasc Ther; 2022 Dec; 29(6):855-865. PubMed ID: 34905961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
    McQuade K; Gable D; Hohman S; Pearl G; Theune B
    J Vasc Surg; 2009 Jan; 49(1):109-15, 116.e1-9; discussion 116. PubMed ID: 19028055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
    McQuade K; Gable D; Pearl G; Theune B; Black S
    J Vasc Surg; 2010 Sep; 52(3):584-90; discussion 590-1, 591.e1-591.e7. PubMed ID: 20598480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II).
    Matsumura JS; Yamanouchi D; Goldstein JA; Pollock CW; Bosiers M; Schultz GA; Scheinert D; Rocha-Singh KJ
    J Vasc Surg; 2013 Jul; 58(1):73-83.e1. PubMed ID: 23642924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stent-grafts are the best way to treat complex in-stent restenosis lesions in the superficial femoral artery: 24-month results from a multicenter randomized trial.
    Bosiers M; Deloose K; Callaert J; Verbist J; Hendriks J; Lauwers P; Schroë H; Lansink W; Scheinert D; Schmidt A; Zeller T; Beschorner U; Noory E; Torsello G; Austermann M; Wauters J
    J Cardiovasc Surg (Torino); 2020 Oct; 61(5):617-625. PubMed ID: 33231029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The DETOUR procedure: no more need for conventional bypass surgery?
    Krievins D; Savlovskis J; Ezite N; Hill A; Kisis K; Gedins M; Zellans E; Holden A
    J Cardiovasc Surg (Torino); 2018 Apr; 59(2):172-177. PubMed ID: 29327570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparin-bonded expanded polytetrafluoroethylene femoropopliteal bypass grafts outperform expanded polytetrafluoroethylene grafts without heparin in a long-term comparison.
    Samson RH; Morales R; Showalter DP; Lepore MR; Nair DG
    J Vasc Surg; 2016 Sep; 64(3):638-47. PubMed ID: 27139782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ZILVERPASS Study: ZILVER PTX Stent vs Bypass Surgery in Femoropopliteal Lesions.
    Bosiers M; Setacci C; De Donato G; Torsello G; Silveira PG; Deloose K; Scheinert D; Veroux P; Hendriks J; Maene L; Keirse K; Navarro T; Callaert J; Eckstein HH; Teβarek J; Giaquinta A; Wauters J
    J Endovasc Ther; 2020 Apr; 27(2):287-295. PubMed ID: 31997715
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug-Eluting Stent Shows Similar Patency Results as Prosthetic Bypass in Patients with Femoropopliteal Occlusion in a Randomized Trial.
    Björkman P; Auvinen T; Hakovirta H; Romsi P; Turtiainen J; Manninen H; Venermo M
    Ann Vasc Surg; 2018 Nov; 53():165-170. PubMed ID: 29886215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of flush superficial femoral artery occlusions with combined open femoral endarterectomy and endovascular femoral-popliteal angioplasty and stent-grafting.
    Hayes DJ; Dougherty MJ; Calligaro KD
    Ann Vasc Surg; 2011 May; 25(4):559.e19-23. PubMed ID: 21549939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study.
    Veraldi GF; Mezzetto L; Macrì M; Criscenti P; Corvasce A; Poli R
    Ann Vasc Surg; 2018 Feb; 47():179-187. PubMed ID: 28943491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retrospective Multicenter Comparison Between Viabahn Covered Stent-Grafts and Supera Interwoven Nitinol Stents for Endovascular Treatment in Severely Calcified Femoropopliteal Artery Disease: The ARMADILLO Study (Adjusted Retrospective coMparison of scAffolDs In caLcified LesiOns).
    Horie K; Takahara M; Nakama T; Tanaka A; Tobita K; Hayakawa N; Mori S; Iwata Y; Suzuki K
    J Endovasc Ther; 2024 Jun; 31(3):400-409. PubMed ID: 36146948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is there an alternative to the surgical above-knee bypass in treatment of superficial femoral artery disease? Experiences with Viabahn stent graft.
    Jebran AF; Popov AF; Zenker D; Bireta C; Friedrich M; Danner BC; Bougioukas I; Schoendube FA; Stojanovic T
    Vasc Endovascular Surg; 2013 Oct; 47(7):502-6. PubMed ID: 23867203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of combined superficial femoral artery endovascular therapy with popliteal-to-distal bypass: A paradigm shift in surgical open bypass for chronic limb-threatening ischemia.
    Kobayashi T; Hamamoto M; Okazaki T; Hasegawa M; Fujiwara T; Takahashi S
    Vascular; 2021 Dec; 29(6):905-912. PubMed ID: 33349196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heparin-Bonded Stent-Graft for the Treatment of TASC II C and D Femoropopliteal Lesions: 36-Month Results of the Viabahn 25 cm Trial.
    Böhme T; Noory E; Brechtel K; Scheinert D; Bosiers M; Beschorner U; Zeller T
    J Endovasc Ther; 2021 Apr; 28(2):222-228. PubMed ID: 33044119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. One-Year Outcomes of Heparin-Bonded Stent-Graft Therapy for Real-World Femoropopliteal Lesions and the Association of Patency With the Prothrombotic State Based on the Prospective, Observational, Multicenter
    Iida O; Takahara M; Soga Y; Yamaoka T; Nanto S; Kuratani T; Sakata Y; Mano T
    J Endovasc Ther; 2021 Feb; 28(1):123-131. PubMed ID: 32959718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First-in-man experience of self-expanding nitinol stents combined with drug-coated balloon in the treatment of femoropopliteal occlusive disease.
    Mwipatayi BP; Perera K; Daneshmand A; Daniel R; Wong J; Thomas SD; Burrows SA
    Vascular; 2018 Feb; 26(1):3-11. PubMed ID: 28436316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three-Year Efficacy and Safety of the Misago Peripheral Stent for Superficial Femoral Artery Disease: Final Results from the OSPREY Trial.
    Angle JF; Gasparetto A; Yokoi H; Jaff MR; Popma JJ; Piegari GN; Iyengar SS; Ohki T
    J Vasc Interv Radiol; 2020 Jun; 31(6):978-985. PubMed ID: 32414572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iliofemoral endarterectomy associated with systematic iliac stent grafting for the treatment of severe iliofemoral occlusive disease.
    Maitrias P; Deltombe G; Molin V; Reix T
    J Vasc Surg; 2017 Feb; 65(2):406-413. PubMed ID: 27693029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.